Sanofi
Search results
Apr 16, 2024 · Boehringer Ingelheim today announced a strong acceleration of its pipeline in 2023, as pivotal trials in key research areas progressed as planned.
Aug 1, 2023 · Boehringer Ingelheim continued expanding its pipeline portfolio through in-house as well as external innovation – 15 new innovation partnerships were formed in areas such as cancer immunology ...
Aug 1, 2023 · INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim, a leading research-driven biopharmaceutical company, continues to advance its pipeline in both Human Pharma and Animal Health expanding ...
Discover Boehringer Ingelheim US Medical and Clinical Resources and explore information on our medical research, clinical developments, and clinical trials.
Boehringer Ingelheim | 1,773,290 followers on LinkedIn. Our people are our strength. And, together with over 56,000 colleagues, we're creating the next breakthrough in the world of health...
Boehringer Ingelheim | Annual Report 2022. Innovation drives us at Boehringer Ingelheim as we strive to positively impact lives of humans and animals with our innovative solutions. In 2022 we were able to help more people than ever before.
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision and the organisation.
